Epigenetic Achilles’ heel of AML
- 25 May 2021
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Nature Cancer
- Vol. 2 (5), 481-483
- https://doi.org/10.1038/s43018-021-00212-w
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry responseNature Cancer, 2021
- Epigenetic targeted therapy of stabilized BAP1 in ASXL1 gain-of-function mutated leukemiaNature Cancer, 2021
- MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanismCancer Cell, 2021
- Clonal hematopoiesis in cancerExperimental Hematology, 2020
- Epigenetic Guardian: A Review of the DNA Methyltransferase DNMT3A in Acute Myeloid Leukaemia and Clonal HaematopoiesisBioMed Research International, 2017
- The R882H DNMT3A Mutation Associated with AML Dominantly Inhibits Wild-Type DNMT3A by Blocking Its Ability to Form Active TetramersCancer Cell, 2014
- Identification of pre-leukaemic haematopoietic stem cells in acute leukaemiaNature, 2014
- Predicting response to epigenetic therapyJCI Insight, 2014
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid LeukemiaThe New England Journal of Medicine, 2013
- A decade of exploring the cancer epigenome — biological and translational implicationsNature Reviews Cancer, 2011